Ipsen: new surveys show over 80% of patients with spasticity and cervical dystonia treated with botulinum toxin-a experience debilitating symptom recurrence

Regulatory news: ipsen (euronext: ipn; adr: ipsey) today presents the results of two patient surveys. the surveys involved over 400 respondents from f
PBH Ratings Summary
PBH Quant Ranking